15 November 2023
Cancers | Highly Cited Special Issues on Cancer Immunology and Immunotherapy in 2022


We are pleased to invite you to read the highly cited Special Issues in 2022 in Cancers (ISSN: 2072-6694) on cancer immunology and immunotherapy. We hope this announcement will provide useful information for this field.

The Special Issues list is as follows:

Tumor Immunology and Immunotherapy Resistance
by Dr. Subbaya Subramanian, Timothy K. Starr and Dr. Xianda Zhao
Viewed by 21600+ | Cited by 40+

Perspectives of Immunotherapy in Tumors of the Gastrointestinal Tract
by Dr. Gianluca Masi
Viewed by 17500+ | Cited by 45+

Immunotherapy of Triple-Negative Breast Cancer
by Dr. Claudia De Lorenzo and Dr. Laura Cerchia
Viewed by 21800+ | Cited by 40+

Cancer Immunotherapy and Immune-Related Adverse Events
by Dr. Shaheen Khan
Viewed by 33900+ | Cited by 110+

Oncolytic Viruses as Cancer Immunotherapy Agents
by Dr. Masataka Suzuki
Viewed by 22100+ | Cited by 70+

Immunotherapy for Solid Tumors
by Dr. Elizabeth Fabre
Viewed by 11800+ | Cited by 60+

You are welcome to view all the Special Issues and submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.

Cancers Editorial Office

Back to TopTop